FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Methotrexate Sodium Injection
Status: Discontinuation
»Therapeutic Categories: Dermatology; Oncology; Pediatric; Rheumatology

Mylan (New 12/16/2019)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
250 mg in 10 mL (25 mg/mL), single dose vial (NDC 67457-466-10) 12/16/2019 Expected Discontinuation April 2020

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English